Compounds > ticlopidine
Page last updated: 2024-11-05

ticlopidine and Neoplasms, Vascular

ticlopidine has been researched along with Neoplasms, Vascular in 2 studies

Ticlopidine: An effective inhibitor of platelet aggregation commonly used in the placement of STENTS in CORONARY ARTERIES.
ticlopidine : A thienopyridine that is 4,5,6,7-tetrahydrothieno[3,2-c]pyridine in which the hydrogen attached to the nitrogen is replaced by an o-chlorobenzyl group.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fernandez-Pineda, I2
Lopez-Gutierrez, JC2
Chocarro, G1
Bernabeu-Wittel, J1
Ramirez-Villar, GL1
Ramirez, G1
Marquez, C1

Trials

1 trial available for ticlopidine and Neoplasms, Vascular

ArticleYear
Long-term outcome of vincristine-aspirin-ticlopidine (VAT) therapy for vascular tumors associated with Kasabach-Merritt phenomenon.
    Pediatric blood & cancer, 2013, Volume: 60, Issue:9

    Topics: Antineoplastic Combined Chemotherapy Protocols; Aspirin; Child, Preschool; Ecchymosis; Female; Follo

2013

Other Studies

1 other study available for ticlopidine and Neoplasms, Vascular

ArticleYear
Vincristine-ticlopidine-aspirin: an effective therapy in children with Kasabach-Merritt phenomenon associated with vascular tumors.
    Pediatric hematology and oncology, 2010, Volume: 27, Issue:8

    Topics: Antineoplastic Combined Chemotherapy Protocols; Aspirin; Disseminated Intravascular Coagulation; Fem

2010